The National Institute of Allergy and Infectious Diseases (NIAID) this week awarded four grants totaling approximately $4.3 million of investment over the first year alone to launch new Tuberculosis Research Advancement Centers (TRACs) across the country.
These grants will last five years, supporting efforts at:
Currently, TB is the second leading cause of death from a single infectious agent worldwide. It is only surpassed by COVID-19. Up to 10 million new cases were diagnosed in 2020, which led to approximately 1.5 million deaths. NIAID considers the bacterial disease a top priority, and these new TRACs will help increase the research workforce, opportunities for multidisciplinary and collaborative research, as well as training in lab and clinical settings.
The 2024 Hurricane Season Campaign began for the Federal Emergency Management Agency (FEMA) this week,…
As a way to support veterans, U.S. Reps. Maria Elvira Salazar (R-FL), Dale Strong (R-AL),…
Mere days after the Department of Homeland Security formed a new Artificial Intelligence (AI) Safety…
KBR will continue to provide life support, equipment readiness, training and supply chain solutions for…
In a bid to update federal spectrum and communications network policy, restore the auction authority…
As a new means to advise the Secretary of Homeland Security and stakeholders, and promote…
This website uses cookies.